Overview: NGS Ataxia Panel Sequencing TestIntroduction: The NGS Ataxia Panel Sequencing Test sequences ataxia-related genes to diagnose ataxia, causing coordination issues. Aligned with 2023 AAN guidelines, it uses PCR for high specificity, supporting neurological screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in molecular pathology for patients with suspected ataxia.
Other Names: Ataxia NGS Assay, Ataxia Gene Panel.
FDA Status: Laboratory-developed test (LDT), meeting molecular pathology standards for diagnostic accuracy.
Historical Milestone: Ataxia sequencing began in the 1990s with cerebellar disorder research. NGS methods improved in the 2010s, enhancing diagnostic precision.
Purpose: Sequences ataxia-related genes to diagnose ataxia, guides treatment, and evaluates patients with coordination issues.
Test Parameters: 1. Ataxia Genes
Pretest Condition: No fasting required. Collect whole blood, buccal swab, or saliva. Report history of coordination issues, tremor, or ataxia symptoms.
Specimen: Whole Blood (EDTA, 2-5 mL), Buccal Swab (sterile swab, 1-2 swabs), Saliva (sterile container, 1-2 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document coordination issues, tremor, dysarthria, or family history of ataxia. Include current medications, especially anticonvulsants.
Consent: Written consent required, detailing the tests purpose, ataxia implications, and risks of sample collection.
Procedural Considerations: Uses next-generation sequencing to analyze ataxia-related genes (e.g., ATXN1, ATXN3). Results are available in 3-5 days, supporting clinical decisions. Performed in laboratories, often for ataxia diagnosis.
Factors Affecting Result Accuracy: Low DNA yield or improper sample storage can affect results. Contamination may reduce specificity.
Clinical Significance: Identified mutations confirm ataxia, guiding supportive care or genetic counseling. Negative results may require broader neurological testing.
Specialist Consultation: Consult a neurologist for result interpretation and treatment planning.
Additional Supporting Tests: Brain MRI, EMG, or neurological exam to confirm ataxia diagnosis.
Test Limitations: Not all ataxia cases are genetic; clinical correlation is needed. Sample quality affects sensitivity.
References: AAN Ataxia Guidelines, 2023; Neurology, Klockgether T, 2022.
